Molecular structure of MS023, CAS Number: 1831110-54-3
MS023 (CAS 1831110-54-3)
CAS Number:
1831110-54-3
Molecular Weight:
287.4
Molecular Formula:
C17H25N3O
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
QUICK LINKS
Ordering Information
Description
Technical Information
Safety Information
SDS & Certificate of Analysis
MS023 (CAS 1831110-54-3) References
- PRMT inhibition induces a viral mimicry response in triple-negative breast cancer. | Wu, Q., et al. 2022. Nat Chem Biol. 18: 821-830. PMID: 35578032
- SpliceTools, a suite of downstream RNA splicing analysis tools to investigate mechanisms and impact of alternative splicing. | Flemington, EK., et al. 2023. Nucleic Acids Res. 51: e42. PMID: 36864749
- Reduced C9orf72 expression exacerbates polyGR toxicity in patient iPSC-derived motor neurons and a Type I protein arginine methyltransferase inhibitor reduces that toxicity. | Dane, TL., et al. 2023. Front Cell Neurosci. 17: 1134090. PMID: 37138766
- Inhibition of type I PRMTs reforms muscle stem cell identity enhancing their therapeutic capacity. | Dominici, C., et al. 2023. Elife. 12: PMID: 37285284
- Protein arginine methyltransferase 1 is a therapeutic vulnerability in multiple myeloma. | Nguyen, HP., et al. 2023. Front Immunol. 14: 1239614. PMID: 37600810
- PRMT inhibitor promotes SMN2 exon 7 inclusion and synergizes with nusinersen to rescue SMA mice. | Kordala, AJ., et al. 2023. EMBO Mol Med. 15: e17683. PMID: 37724723
- Type-I protein arginine methyltransferase inhibition primes anti-programmed cell death protein 1 immunotherapy in triple-negative breast cancer. | Zhang, S., et al. 2024. Cancer. 130: 1415-1423. PMID: 38079306
- PRMT blockade induces defective DNA replication stress response and synergizes with PARP inhibition. | Li, Y., et al. 2023. Cell Rep Med. 4: 101326. PMID: 38118413
- Asymmetric and symmetric protein arginine methylation in methionine-addicted human cancer cells. | Holtz, AG., et al. 2023. PLoS One. 18: e0296291. PMID: 38134182
- PRMT1 in human neoplasm: cancer biology and potential therapeutic target. | Shen, S., et al. 2024. Cell Commun Signal. 22: 102. PMID: 38326807
- Inhibition of epigenetic and cell cycle-related targets in glioblastoma cell lines reveals that onametostat reduces proliferation and viability in both normoxic and hypoxic conditions. | Lavogina, D., et al. 2024. Sci Rep. 14: 4303. PMID: 38383756
- Enhancement of PRMT6 binding to a novel germline GATA1 mutation associated with congenital anemia. | Lu, Y., et al. 2024. Haematologica.. PMID: 38385251
- The antidepressant effects of protein arginine methyltransferase 2 involve neuroinflammation. | Liu, S., et al. 2024. Neurochem Int. 176: 105728. PMID: 38561150
Inhibitor of:
AEBP2, AU022751, BRPF3, Dimethyl Arg Symmetric, Dimethyl Histone H3, L3MBTL3, Monomethyl Arg Symmetric, PHRF1, PRA1, PRMT1, PRMT10, PRMT5, PRMT6, PRMT8, RBM3, SUV420H1, Trimethyl Arg Symmetric, and Trimethyl Histone H3.Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
MS023, 5 mg | sc-507463 | 5 mg | $165.00 |